SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 42 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $272,000 | -0.7% | 377,244 | 0.0% | 0.03% | +13.3% |
Q2 2019 | $274,000 | -40.2% | 377,244 | 0.0% | 0.03% | -44.4% |
Q1 2019 | $458,000 | +191.7% | 377,244 | 0.0% | 0.05% | +200.0% |
Q4 2018 | $157,000 | -81.6% | 377,244 | -11.8% | 0.02% | -79.1% |
Q3 2018 | $855,000 | -5.7% | 427,642 | 0.0% | 0.09% | -7.5% |
Q2 2018 | $907,000 | -25.9% | 427,642 | -5.0% | 0.09% | -38.4% |
Q1 2018 | $1,224,000 | -26.3% | 450,100 | 0.0% | 0.15% | -32.6% |
Q4 2017 | $1,661,000 | – | 450,100 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,600,000 | $1,092,000 | 1.15% |
BVF INC/IL | 2,287,860 | $951,000 | 0.12% |
Eventide Asset Management | 2,265,455 | $942,000 | 0.04% |
SABBY MANAGEMENT, LLC | 400,140 | $166,000 | 0.04% |
RP Management, LLC | 129,517 | $54,000 | 0.04% |
Palo Alto Investors LP | 1,162,473 | $483,000 | 0.03% |
NEA Management Company, LLC | 1,298,274 | $539,000 | 0.02% |
Rhenman & Partners Asset Management AB | 377,244 | $157,000 | 0.02% |
GREAT POINT PARTNERS LLC | 317,962 | $132,000 | 0.02% |
Vivo Capital, LLC | 195,474 | $81,000 | 0.01% |